Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: creating a larger donor pool
Affiliations
- PMID: 8266553
Item in Clipboard
Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: creating a larger donor pool
Transplant Proc.
1993 Dec.
No abstract available
Similar articles
-
The value of hormonal therapy in improving organ viability in the transplant donor.Transplant Proc. 1987 Feb;19(1 Pt 3):2037-8. Transplant Proc. 1987. PMID: 3079070 No abstract available.
-
Triiodothyronine therapy for heart donor and recipient.J Heart Transplant. 1988 Sep-Oct;7(5):370-6. J Heart Transplant. 1988. PMID: 3058907
-
Hemodynamic and metabolic effects of substitutive triiodothyronine therapy in organ donors.Transplant Proc. 1993 Dec;25(6):3038-9. Transplant Proc. 1993. PMID: 8266444 No abstract available.
-
Triiodothyronine replacement, the euthyroid sick syndrome, and organ transplantation.Transplant Proc. 1991 Oct;23(5):2460-2. Transplant Proc. 1991. PMID: 1926432 Review. No abstract available.
-
Heart transplantation, euthyroid sick syndrome, and triiodothyronine replacement.J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 2):S196-8. J Heart Lung Transplant. 1992. PMID: 1515440 Review. No abstract available.
Cited by
-
Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats.J Mol Cell Cardiol. 2008 Jan;44(1):180-7. doi: 10.1016/j.yjmcc.2007.09.009. Epub 2007 Oct 26. J Mol Cell Cardiol. 2008. PMID: 17964598 Free PMC article.
-
Nonthyroidal Illness Syndrome: To Treat or Not to Treat? Have We Answered the Question? A Review of Metanalyses.Front Endocrinol (Lausanne). 2022 May 10;13:850328. doi: 10.3389/fendo.2022.850328. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35620389 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical